- Home
- SUGP vs CPIX Comparison
SUGP vs CPIX Comparison
Compare SUGP & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUGP
- CPIX
- Stock Information
- Founded
- SUGP 1998
- CPIX 1999
- Country
- SUGP Hong Kong
- CPIX United States
- Employees
- SUGP N/A
- CPIX N/A
- Industry
- SUGP
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- SUGP
- CPIX Health Care
- Exchange
- SUGP NYSE
- CPIX Nasdaq
- Market Cap
- SUGP 20.3M
- CPIX 17.2M
- IPO Year
- SUGP 2024
- CPIX 2009
- Fundamental
- Price
- SUGP $0.98
- CPIX $2.36
- Analyst Decision
- SUGP
- CPIX
- Analyst Count
- SUGP 0
- CPIX 0
- Target Price
- SUGP N/A
- CPIX N/A
- AVG Volume (30 Days)
- SUGP 67.1K
- CPIX 5.5M
- Earning Date
- SUGP 02-02-2025
- CPIX 11-07-2024
- Dividend Yield
- SUGP N/A
- CPIX N/A
- EPS Growth
- SUGP N/A
- CPIX N/A
- EPS
- SUGP 0.10
- CPIX N/A
- Revenue
- SUGP $20,252,232.00
- CPIX $36,785,442.00
- Revenue This Year
- SUGP N/A
- CPIX N/A
- Revenue Next Year
- SUGP N/A
- CPIX N/A
- P/E Ratio
- SUGP $10.13
- CPIX N/A
- Revenue Growth
- SUGP N/A
- CPIX N/A
- 52 Week Low
- SUGP $0.76
- CPIX $1.04
- 52 Week High
- SUGP $5.86
- CPIX $3.05
- Technical
- Relative Strength Index (RSI)
- SUGP 33.64
- CPIX 66.16
- Support Level
- SUGP $0.76
- CPIX $2.07
- Resistance Level
- SUGP $1.65
- CPIX $2.93
- Average True Range (ATR)
- SUGP 0.23
- CPIX 0.26
- MACD
- SUGP -0.09
- CPIX 0.08
- Stochastic Oscillator
- SUGP 19.82
- CPIX 53.06
About SUGP SU GROUP HLDGS LTD
SU Group Holdings Ltd and its subsidiaries is an integrated security-related services company. The company has two reportable segments: security-related engineering services, and security guarding and screening services and related vocational training services. The company generates the majority of its revenue from the security-related engineering services segment.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.